Exome sequencing identifies ADGRG4 G-protein-coupled receptors gene as a novel cancer biomarker in ovarian cancer patients from North India.

Autor: Sharma M; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India., Verma S; Indian Council of Medical Research-Centre for Advance Research, Shri Mata Vaishno Devi University, Katra, India., Angurana SL; Department of Radiotherapy and Oncology, AIIMS, Vijaypur, India., Tufail Z; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India., Bhagat V; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India., Nagyal S; Department of Histopathology, Shri Mata Vaishno Devi Narayana Multispeciality Clinic, Shri Mata Vaishno Devi Narayana Superspeciality Hospital, Katra, India., Jamwal RS; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India., Sharma B; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India., Shah R; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India, Jammu & Kashmir, India., Bhat A; Centre for Molecular Biology, Central University of Jammu, Jammu & Kashmir, India., Chander G; Indian Council of Medical Research-Centre for Advance Research, Shri Mata Vaishno Devi University, Katra, India., Kumar R; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India.; Indian Council of Medical Research-Centre for Advance Research, Shri Mata Vaishno Devi University, Katra, India.
Jazyk: angličtina
Zdroj: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Mar; Vol. 38 (3), pp. e23672.
DOI: 10.1002/jbt.23672
Abstrakt: Adhesion G protein-coupled receptor G4 (ADGRG4) is a G protein-coupled receptor (GPCR) that belongs to the adhesion family. Participation of ADGRG4 in cell adhesion and migration, signaling pathway activation, influence on angiogenesis, and modulation of immune responses are some of the possible ways through which it may contribute to oncogenesis. Conducting extensive omics studies poses budgetary challenges to small labs in peripheral areas, primarily due to restricted research funding and resource limitations. Here we propose a low-budget model for biomarker screening. A total of 11 ovarian cancer samples were sent for exome sequencing. Among various genes, ADGRG4 variants were present in all 11 samples and thus were chosen as a potential biomarker in the present population. However, the precise role of ADGRG4 in cancer is not fully understood. The present study aims to look at the association between the ADGRG4 gene variants and their risk of ovarian cancer in the North Indian region of Jammu and Kashmir, India. Overall, 235 individuals (115 cases and 120 healthy controls) were genotyped for the selected biomarker using Sanger sequencing. Logistic regression was used to assess the relationship between the variant and ovarian cancer. A statistically significant association was identified between the ADGRG4 variant rs5930932 polymorphism and the incidence of ovarian cancer among the study population. When corrected for age and BMI, the dominating OR of variant rs5930932 was 1.035 (1.003-1.069) under HWE patients (0.95) and controls (0.18), with a p-value of (0.03). According to the findings of the current investigation, the ADGRG4 gene variant rs5930932 increases the chance of developing ovarian cancer in the studied population.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: